Repatha (Evolocumab) and Sildenafil Interaction: Safety, Evidence, and Clinical Guidance

Repatha and sildenafil have no identified pair-specific interaction in their prescribing information, and their pharmacology does not suggest that they need to be spaced apart. The medication review should concentrate on sildenafil's other interactions and the person's cardiovascular condition. [1,2]

This conclusion comes from the two medicines' labeled properties. It does not require assuming that a cholesterol trial separately tested every medicine participants might have taken.

Why these medicines can appear on the same medication list

Repatha, or evolocumab, lowers LDL cholesterol by binding PCSK9, allowing more LDL receptors to remain available to remove cholesterol from the blood. Sildenafil inhibits PDE5. It is used as Viagra for erectile dysfunction and as Revatio for pulmonary arterial hypertension. [1-3]

A person receiving treatment for cholesterol can also need treatment for either of those sildenafil indications. The indication matters because the dosing schedules differ, even though the active ingredient is the same.

How the body processes each drug

Repatha's label describes an approximately 20% reduction in evolocumab exposure with high-intensity statins, without a clinically meaningful effect on its LDL response. [1] This is a useful distinction: biologic medicines can have interaction data, even when a particular enzyme-mediated interaction is not expected.

There is no labeled instruction to lower either dose specifically because evolocumab and sildenafil are used together. Choose each dose for its own indication and the rest of the medication list.

Same-day dosing and blood pressure

The reviewed prescribing information does not call for a waiting interval between a Repatha injection and a sildenafil dose. [1,2] Moving sildenafil to the next day is not an established way to improve this combination.

Sildenafil can lower blood pressure. Repatha is a cholesterol-lowering medicine, not a treatment whose intended action is an immediate fall in blood pressure. This makes the rest of the medication list more useful than the injection date when assessing dizziness or lightheadedness.

For example, a person taking Repatha, sildenafil and an alpha-blocker has a medication review involving the alpha-blocker and sildenafil. Focusing only on the newest injection could miss that existing interaction.

The sildenafil interactions that change the plan

The Viagra label identifies these practical distinctions: [2]

These Viagra instructions should not be copied onto a Revatio prescription without considering its pulmonary-hypertension regimen.

Why the reason for sildenafil matters

Revatio uses scheduled dosing for pulmonary arterial hypertension. The current adult labeling starts at 20 mg three times daily and permits titration up to 80 mg three times daily when needed, based on symptoms and tolerability. Its instructions address interactions in that treatment setting. [3]

An as-needed erectile-dysfunction plan is not a replacement for a scheduled pulmonary-hypertension plan. When discussing the combination with a pharmacist, provide the actual prescription and frequency, rather than only the name "sildenafil."

Cardiovascular disease and sexual activity

The Princeton IV consensus evaluates cardiovascular fitness for sexual activity alongside erectile-dysfunction treatment. Stable cardiovascular disease and severe or unstable cardiac disease call for different assessments. Cholesterol treatment does not by itself establish that a person is ready for sexual activity or remove sildenafil's nitrate interaction. [4]

Princeton IV recommends avoiding nitrates within 24 hours after sildenafil. That is not a self-administered nitroglycerin clearance rule: the Viagra label does not establish that nitrate administration becomes safe automatically at the 24-hour point. If chest pain occurs after sildenafil, seek emergency care and report when the last dose was taken. [2,4]

This is relevant to people with a cardiovascular medication list whether or not it contains Repatha.

What the Repatha cardiovascular trial shows

FOURIER randomized 27,564 people with established atherosclerotic cardiovascular disease receiving statin therapy to evolocumab or placebo. During median follow-up of 2.2 years, the primary composite cardiovascular outcome occurred in 9.8% versus 11.3%, respectively, with a hazard ratio of 0.85. [5]

That result demonstrates a cardiovascular benefit of evolocumab in the studied population. It is not a sildenafil interaction study, and the published overall outcome should not be repackaged as proof that a specific sildenafil subgroup was tested.

The trial helps explain why Repatha is prescribed. The product pharmacology and the full medication list answer the separate interaction question.

What to record if symptoms start

A short timeline is more helpful than guessing which drug caused the symptom:

• The Repatha injection date and dose.
• The sildenafil dose, indication and time taken.
• Other medicines taken around that time, including any recently added prescription.
• The symptom, its onset and duration, and a blood-pressure reading if available.
• Whether the same symptom happened with earlier doses.

Keep the symptom assessment separate from the interaction assessment. A medicine can cause a side effect without interacting with the other drug.

Chest pain, fainting, sudden vision loss, an erection lasting more than four hours, or swelling with breathing difficulty warrants urgent evaluation. Do not assume these symptoms are explained by an otherwise unlisted Repatha-sildenafil interaction. [2,3]

Common questions

Do I need to skip Repatha on a day I use sildenafil?

The prescribing information does not specify such a schedule change for this pair. The prescriber should resolve any separate sildenafil interaction or cardiovascular concern.

Does lowering LDL prevent sildenafil-related dizziness?

LDL treatment and a short-term blood-pressure response are different issues. Review sildenafil timing, other medications and symptoms rather than using the cholesterol result to predict dizziness.

Does a normal blood pressure make sildenafil with nitrates acceptable?

No. The nitrate interaction still applies. A normal starting measurement does not remove it. [2]

What is the most useful question to ask the pharmacist?

"I take Repatha and sildenafil at these doses, for these reasons. Does anything else on my medication list change the sildenafil plan?" Include prescriptions taken only occasionally, not just daily medicines.

References

1. DailyMed. Repatha prescribing information, updated August 2026.
2. Pfizer. Viagra prescribing information.
3. FDA. Revatio prescribing information, 2024.
4. Kloner and colleagues. Princeton IV consensus guidelines on PDE5 inhibitors and cardiac health, 2024.
5. Sabatine and colleagues. FOURIER: evolocumab and cardiovascular outcomes, 2017.